예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률>중동 및 아프리카 두개악안면 임플란트 시장, 유형별(뼈 이식 대체물, 중안면 임플란트, 두개골/신경 임플란트, 하악 교정 임플란트, 분산 시스템, 두개골 플랩 고정 시스템, 총 측두하악(TMJ) 교체 시스템, 환자별 임플란트(PSI), 경막 수리 제품 및 기타), 구성 재료(금속, 뼈 이식 대체물, 폴리머/생체재료 및 기타), 적용 부위(외부 고정 장치 및 내부 고정 장치), 수술 유형( 재건 수술 , 외상 수술, 성형 수술, 교정 수술, 치과 수술, 이비인후과 수술 및 기타), 속성 유형(흡수성 고정 장치, 비흡수성 고정 장치), 최종 사용자(병원, 전문 병원, 외상 센터, 외래 수술 센터(ASC), 기타), 유통 채널 (직접 입찰 및 소매 판매) - 업계 동향 및 2030년까지의 전망.
중동 및 아프리카 두개악안면 임플란트 시장 분석 및 규모
중동 및 아프리카 두개악안면 임플란트 시장은 Zimmer Biomet, Medtronic, DePuy Synthes, Stryker 등과 같은 많은 글로벌 기업으로 구성되어 있습니다. 이러한 기업의 존재는 이 지역 전체의 두개악안면 임플란트에 대한 경쟁력 있는 가격을 제공합니다. 지역 및 국제 수준에서 이러한 기업이 존재하기 때문에 공급업체와 제조업체는 모든 예산에서 다양한 사양과 특성을 가진 제품을 제공합니다. 선천적 안면 기형의 유병률이 증가함에 따라 시장 성장이 촉진되고 있습니다. 또한 외상 사례와 교통사고의 증가로 인해 시장 성장이 촉진될 것으로 예상됩니다.
Data Bridge Market Research는 중동 및 아프리카 두개악안면 임플란트 시장이 2030년까지 9,681만 달러 규모에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 5.4%라고 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
매출은 백만, 볼륨은 단위, 가격은 USD로 표시 |
|
다루는 세그먼트 |
유형(뼈 이식 대체물, 중안면 임플란트, 두개골/신경 임플란트, 하악교정 임플란트, 분산 시스템, 두개골 플랩 고정 시스템, 총 측두하악(TMJ) 교체 시스템, 환자별 임플란트(PSI), 경막 수리 제품 및 기타), 구성 재료(금속, 뼈 이식 대체물, 폴리머/생체재료 및 기타), 적용 부위(외부 고정 장치 및 내부 고정 장치), 수술 유형(재건 수술, 외상 수술, 성형 수술, 교정 수술, 치과 수술, 이비인후과 수술 및 기타), 속성 유형(흡수성 고정 장치, 비흡수성 고정 장치), 최종 사용자(병원, 전문 병원, 외상 센터, 외래 수술 센터(ASC), 기타), 유통 채널(직접 입찰 및 소매 판매) |
|
적용 국가 |
Saudi Arabia, South Africa, U.A.E., Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
Zimmer Biomet (U.S.), Medtronic (U.S.), DePuy Synthes (U.S.), Stryker (U.S.), KLS Martin Group (U.S.), Jeil Medical Corp (South Korea), Anatomics Pty Ltd (Australia), Xilloc Medical Int B.V. (Netherlands), Teknimed (France), Bioplate Inc. (U.S.), Poriferous (U.S.), Innovasis, Inc.(U.S.), DIMEDA Instrumente GmbH (Germany) and Advin Healthcare (India) |
Market Definition
Craniomaxillofacial implants are employed for craniomaxillofacial surgeries. Craniomaxillofacial abnormalities occur during childbirth due to the mother's folic acid deficiency or genetic mutations. Facial defects also damage speech, eating, and language, and cause dental problems and hearing loss. It is generally performed to treat injuries, defects, and diseases in the head, neck, face, jaws, and hard and soft tissues of the oral and maxillofacial region. The increase in the geriatric population and the rise in the prevalence of bowel and bladder cancer are accelerating the growth of the market. Additionally, an adaptation of advanced technologies in the industry has stimulated market growth consequently. On the other hand, the growing demand for patients-specific implants in surgeries is likely to drive market growth in the projected period.
Middle East and Africa Craniomaxillofacial Implants Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
Rising prevalence rate of congenital facial deformities
Craniofacial deformities can range from small defects to disfiguring clefts and other malformations. Deformities can either be congenital (born with) or acquired through trauma, illness, or surgeries. Correcting these malformations requires the experience and expertise of reconstructive plastic surgeons and an entire craniofacial team.
Each patient’s situation and needs are unique. Most patients require multiple procedures performed over the course of several years. Moreover, increased cases of congenital facial deformities is expected to drive the growth of the Middle East and Africa craniomaxillofacial implants market.
For instance,
- The global registry and database on craniofacial anomalies, states that Congenital Anomalies (CA) are a major cause of infant mortality and childhood morbidity, affecting 2-3% of all babies. Approximately 1% of these newborns have syndromes or multiple anomalies. The study also estimated that 30% of cleft cases are syndromic and approximately 70% are non-syndromic.
According to the EarWell Center of Excellence, Craniofacial Deformities have more than 28 types of severe syndromes.
Therefore, rising prevalence of congenital facial deformities, is expected to drive the growth of the Middle East and Africa craniomaxillofacial implants market.
Increase in trauma cases and road accidents
Road accidents and trauma cases may cause brain damage and other complications, such as bruising, bleeding, and infection of the brain. These injuries can lead to loss of consciousness, confusion, memory lapses, and limb paralysis. These conditions can be either temporary or permanent, and surgery may be required. Road accident is one of the key causes of CMF injuries across the globe.
For instance,
- On June 21, 2021, WHO published a report that stated Approximately 1.3 million people die each year as a result of road traffic crashes. 93% of the world's fatalities on the roads occur in low- and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Moreover, road traffic injuries are the leading cause of death for children and young adults aged 5-29 years.
- According to the South African Medical Research Council, trauma is responsible for over 60,000 deaths in South Africa each year. This includes deaths from road accidents, interpersonal violence, and other forms of trauma.
Moreover, sports injuries, which require craniomaxillofacial surgeries include injuries related to nasal bone, facial fracture, mandibular fracture, and others. Thus, rising cases of road accidents and trauma further drive the Middle East and Africa craniomaxillofacial implants market growth.
Opportunity
Rise in healthcare expenditure & infrastructure
Advancement in technologies and development in healthcare infrastructure is significantly impacting the market growth. Development in healthcare infrastructure is anticipated to provide better patient services during surgeries and establish a new healthcare delivery system. Advanced healthcare facility design and implementation of advanced technology is anticipated to accelerate the market growth
Development in healthcare infrastructure induces owing to factors, such as insurance penetration, affordability of the population, raising income, heightened average life span of the populace, encouraging medical tourism flow, and growing concern for cosmetic treatments among others.
Moreover, government bodies and healthcare organizations are supporting low and middle income countries to develop healthcare infrastructure.
For instance,
- The government of Zambia has been increasing its healthcare budget allocation in recent years to improve the quality of healthcare services and address the country's healthcare challenges. In 2021, the government allocated ZMW 8.7 billion to the health sector, an increase of 23% from the previous year.
- Zambia's healthcare expenditure has been steadily increasing over the years, from ZMW 3.1 billion in 2010 to ZMW 9.8 billion in 2019, according to data from the World Bank.
Restraint/Challenge
Lack of awareness in developing countries
People are highly unaware of craniomaxillofacial implants and the surgeries related to them. Countries that are underdeveloped or still in the developing stage show a lack of awareness about craniomaxillofacial implants. In addition, people are unaware of the reimbursement and the coverage they can get. Thus, many government organizations are taking part in spreading awareness about craniomaxillofacial implants through conferences and publishing research articles not just to the public but to medical practitioners as well.
For instance,
- In 2019, a study published in the Journal of Craniofacial Surgery found that there was a lack of awareness and knowledge about craniomaxillofacial surgery among healthcare professionals in sub-Saharan Africa. The study noted that this lack of awareness was leading to delays in diagnosis and treatment for patients with craniofacial deformities.
- In 2018, a report by the World Health Organization (WHO) noted that there was a shortage of skilled healthcare professionals, including surgeons, in many countries in the Middle East and Africa. This shortage was identified as a major barrier to improving access to specialized care, including craniomaxillofacial surgery.
Craniomaxillofacial implants have emerged as a widely accepted prosthetic treatment option. However, lack of public awareness and cost of the treatment act as barriers which is expected to limit the market growth.
Post-COVID-19 Impact on the Middle East and Africa Craniomaxillofacial Implants Market
COVID-19 created a negative impact on the Middle East and Africa craniomaxillofacial implants market. The lockdown restriction led to the emergence of various challenges such as decreased hospital visits and delays in treatment procedures.
The COVID-19 pandemic has impacted the market to an extent in negative manner. However, increasing government support and advancements in imaging techniques is expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel the market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve surgical techniques for craniomaxillofacial implants. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In 2021, DePuy Synthes launched a new craniomaxillofacial implant system in Africa. The system features 3D-printed titanium plates and screws that are designed to provide better stability and reduce the risk of complications in complex cranial and facial reconstructions.
- 2020년, 남아프리카 의료 기술 회사인 Maxillofacial Technologies는 새로운 두개악안면 임플란트 및 기구 라인을 출시했습니다. 이 제품에는 환자 결과를 개선하고 수술 시간을 단축하도록 설계된 맞춤형 티타늄 임플란트가 포함됩니다.
- 2019년, Medtronic은 중동과 아프리카에서 두개악안면외과 수술을 위한 새로운 티타늄 임플란트 시스템을 출시했습니다. 이 시스템은 환자 결과를 개선하고 수술 시간을 단축하도록 설계된 다양한 임플란트와 기구를 갖추고 있습니다.
중동 및 아프리카 두개악안면 임플란트 시장 범위
중동 및 아프리카 두개악안면 임플란트 시장은 유형, 건설 재료, 적용 부위, 수술 유형, 부동산 유형, 최종 사용자 및 유통 채널을 기준으로 7개의 주요 세그먼트로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
유형
- 뼈 이식 대체물
- 중안면 임플란트
- 두개골/신경 임플란트
- 하악교정 임플란트
- 주의 산만 시스템
- 두개골 플랩 고정 시스템
- 전체 측두하악(TMJ) 교체 시스템
- 환자 맞춤형 임플란트(PSI)
- 경막수리제품
- 기타
시장은 유형에 따라 뼈 이식 대체물, 중안면 임플란트, 두개골/신경 임플란트, 하악 교정 임플란트, 분산 시스템, 두개골 플랩 고정 시스템, 총 측두하악(TMJ) 교체 시스템, 환자 맞춤형 임플란트(PSI), 경막 수리 제품 및 기타로 구분됩니다.
구성 재료
- 궤조
- 뼈 이식 대체물
- 폴리머/생체재료
- 기타
시장은 구성 재료에 따라 금속, 뼈 이식 대체물, 폴리머/생체재료 및 기타로 구분됩니다.
신청 사이트
- 외부 고정 장치
- 내부 고정 장치
시장은 적용 부위에 따라 외부 고정 장치와 내부 고정 장치로 구분됩니다.
수술 유형
- 재건 수술
- 외상 수술
- 성형수술
- 정형외과 수술
- 치과 수술
- 이비인후과 수술
- 기타
수술 유형을 기준으로 시장은 재건 수술, 외상 수술, 성형 수술, 악교정 수술, 치과 수술, 이비인후과 수술 및 기타 수술로 구분됩니다.
부동산 유형
- 흡수성 고정 장치
- 비흡수성 고정장치
부동산 유형에 따라 시장은 흡수성 고정제와 비흡수성 고정제로 구분됩니다.
최종 사용자
- 병원
- 전문 클리닉
- 트라우마 센터
- 외래 수술 센터(ASC)
- 기타
최종 사용자를 기준으로 시장은 병원, 전문 클리닉, 외상 센터, 외래 수술 센터(ASC) 및 기타로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 판매
유통 채널을 기준으로 시장은 직접 입찰과 소매 판매로 구분됩니다.
중동 및 아프리카 두개악안면 임플란트 시장 지역 분석/통찰력
중동 및 아프리카 두개악안면 임플란트 시장을 분석하고, 위에 언급된 대로 국가, 유형, 구성 재료, 적용 장소, 수술 유형, 부동산 유형, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 시장 보고서에서 다루는 국가는 남아프리카, 사우디 아라비아, UAE, 이집트, 이스라엘, 중동 및 아프리카의 나머지 지역입니다. 사우디 아라비아는 가장 큰 시장 점유율로 시장을 지배하고 있습니다. 이 점유율은 Zimmer Biomet, Medtronic, DePuy Synthes, Stryker 등과 같은 주요 시장 참여자의 존재에 기인합니다. 선천적 안면 기형의 유병률이 증가함에 따라 이 지역의 예측 기간 동안 시장 성장이 촉진될 것으로 예상됩니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터의 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 중동 및 아프리카 두개악안면 임플란트 시장 점유율 분석
중동 및 아프리카 두개악안면 임플란트 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
중동 및 아프리카 두개악안면 임플란트 시장에서 활동하는 주요 기업으로는 Zimmer Biomet(미국), Medtronic(미국), DePuy Synthes(미국), Stryker(미국), KLS Martin Group(미국), Jeil Medical Corp(한국), Anatomics Pty Ltd(호주), Xilloc Medical Int BV(네덜란드), Teknimed(프랑스), Bioplate Inc.(미국), Poriferous(미국), Innovasis, Inc.(미국), DIMEDA Instrumente GmbH(독일), Advin Healthcare(인도) 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES MODEL
5 INDUSTRIAL INSIGHTS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE RATE OF CONGENITAL FACIAL DEFORMITIES
6.1.2 INCREASE IN TRAUMA CASES AND ROAD ACCIDENTS
6.1.3 INCREASING DEMAND FOR FACIAL RECONSTRUCTION SURGERY
6.1.4 RECENT TECHNOLOGICAL ADVANCEMENTS IN CMF IMPLANTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF SURGERIES AND IMPLANTS
6.2.2 IMPLANT MALFUNCTION AND ASSOCIATED RISK
6.2.3 LACK OF AWARENESS FOR CRANIOMAXILLOFACIAL SURGERY
6.3 OPPORTUNITIES
6.3.1 GROWING GERIATRIC POPULATION
6.3.2 RISE IN HEALTHCARE EXPENDITURE & INFRASTRUCTURE
6.3.3 GROWING R&D ACTIVITIES AND TECHNOLOGICAL ADVANCEMENT
6.3.4 INCREASE IN DEMAND FOR CUSTOMIZED AND PATIENT-SPECIFIC IMPLANTS
6.4 CHALLENGES
6.4.1 INCREASE IN PRODUCT RECALL
6.4.2 POST SURGERY COMPLIACTION
7 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 BONE GRAFT SUBSTITUTE
7.2.1 NATURAL
7.2.2 SYNTHETIC
7.3 MID-FACE IMPLANTS
7.3.1 PLATES
7.3.2 SCREWS
7.4 CRANIAL/NEURO IMPLANTS
7.4.1 PLATES
7.4.2 SCREWS
7.4.3 CONTOURABLE MESHES
7.5 MANDIBULAR ORTHOGNATHIC IMPLANTS
7.5.1 PLATES
7.5.2 SCREWS
7.6 DISTRACTION SYSTEM
7.7 CRANIAL FLAP FIXATION SYSTEM
7.8 PATIENT SPECIFIC IMPLANTS (PSI)
7.8.1 METAL
7.8.2 PLASTIC
7.8.3 OTHERS
7.8.4 NORMAL
7.8.5 3D PRINTED
7.8.6 CAD
7.8.7 ADEPT SOFTWARE
7.8.8 CAM
7.8.9 OTHERS
7.9 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
7.1 DURAL REPAIR PRODUCTS
7.10.1 DURAL SEALANTS
7.10.2 DURAL SUBSTITUTES
7.11 OTHERS
8 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION
8.1 OVERVIEW
8.2 METALS
8.2.1 TITANIUM AND ALLOYS
8.2.2 STAINLESS STEEL
8.2.3 POLYETHERETHERKETONE (PEEK)
8.2.4 SILICON NITRIDE
8.2.5 OTHERS
8.3 BONE GRAFT SUBSTITUTE
8.4 POLYMERS/BIOMATERIAL
8.5 OTHERS
9 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE
9.1 OVERVIEW
9.2 INTERNAL FIXATORS
9.2.1 BONE GRAFT SUBSTITUTE
9.2.2 MID-FACE IMPLANTS
9.2.3 CRANIAL/NEURO IMPLANTS
9.2.4 MANDIBULAR ORTHOGNATHIC IMPLANTS
9.2.5 DISTRACTION SYSTEM
9.2.6 CRANIAL FLAP FIXATION SYSTEMS
9.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS
9.2.8 OTHERS
9.3 EXTERNAL FIXATORS
9.3.1 DISTRACTION SYSTEM
9.3.2 OTHERS
10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE
10.1 OVERVIEW
10.2 RECONSTRUCTIVE SURGERY
10.2.1 BONE GRAFT SUBSTITUTE
10.2.2 MID-FACE IMPLANTS
10.2.3 CRANIAL/NEURO IMPLANTS
10.2.4 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.2.5 DISTRACTION SYSTEM
10.2.6 CRANIAL FLAP FIXATION SYSTEMS
10.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.2.8 DURAL REPAIR PRODUCTS
10.2.9 OTHERS
10.3 TRAUMA SURGERIES
10.3.1 BONE GRAFT SUBSTITUTE
10.3.2 MID-FACE IMPLANTS
10.3.3 CRANIAL/NEURO IMPLANTS
10.3.4 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.3.5 DISTRACTION SYSTEM
10.3.6 CRANIAL FLAP FIXATION SYSTEMS
10.3.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.3.8 DURAL REPAIR PRODUCTS
10.3.9 OTHERS
10.4 PLASTIC SURGERIES
10.4.1 MID-FACE IMPLANTS
10.4.2 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.4.3 CRANIAL/NEURO IMPLANTS
10.4.4 DISTRACTION SYSTEM
10.4.5 CRANIAL FLAP FIXATION SYSTEMS
10.4.6 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.4.7 OTHERS
10.5 ORTHOGNATHIC SURGERIES
10.5.1 BONE GRAFT SUBSTITUTE
10.5.2 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.5.3 DISTRACTION SYSTEM
10.5.4 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.5.5 OTHERS
10.6 DENTAL SURGERIES
10.6.1 DISTRACTION SYSTEM
10.6.2 OTHERS
10.7 ENT SURGERIES
10.7.1 BONE GRAFT SUBSTITUTE
10.7.2 MID-FACE IMPLANTS
10.7.3 OTHERS
10.8 OTHERS
11 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE
11.1 OVERVIEW
11.2 NON-RESORBABLE FIXATORS
11.3 RESORBABLE FIXATORS
12 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 SPECIALTY CLINICS
12.4 TRAUMA CENTERS
12.5 AMBULATORY SURGICAL CENTERS (ASCS)
12.6 OTHERS
13 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
14 MIDDLE EAST AND AFRICA
14.1 SAUDI ARABIA
14.2 SOUTH AFRICA
14.3 U.A.E.
14.4 ISRAEL
14.5 EGYPT
14.6 REST OF MIDDLE EAST AND AFRICA
15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ZIMMER BIOMET
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 RODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 MEDTRONIC
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 DEPUY SYNTHES
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 STRYKER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 KLS-MARTIN GROUP
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENT
17.6 ADVIN HEALTH CARE
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 ANATOMICS PTY LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 BIOPLATE INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 DIMEDA INSTRUMENTE GMBH
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 INNOVASIS INC.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 JEIL MEDICAL CORPORATION
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 PORIFEROUS
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.12.4 MANUFACTURING CERTIFICATION
17.13 TEKNIMED
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.13.4 MDSAP CERTIFICATION
17.14 XILLOC MEDICAL BV
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 26 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 SAUDI ARABIA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 28 SAUDI ARABIA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 29 SAUDI ARABIA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 30 SAUDI ARABIA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 31 SAUDI ARABIA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 SAUDI ARABIA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 33 SAUDI ARABIA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 SAUDI ARABIA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 35 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 36 SAUDI ARABIA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 37 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 38 SAUDI ARABIA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 39 SAUDI ARABIA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 40 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 41 SAUDI ARABIA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 42 SAUDI ARABIA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 43 SAUDI ARABIA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 44 SAUDI ARABIA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 45 SAUDI ARABIA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 46 SAUDI ARABIA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 47 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 48 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 50 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 SOUTH AFRICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 SOUTH AFRICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 53 SOUTH AFRICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 SOUTH AFRICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 SOUTH AFRICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 SOUTH AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 57 SOUTH AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 SOUTH AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 59 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 60 SOUTH AFRICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 61 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 62 SOUTH AFRICA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 63 SOUTH AFRICA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 64 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 65 SOUTH AFRICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 66 SOUTH AFRICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 67 SOUTH AFRICA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 68 SOUTH AFRICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 69 SOUTH AFRICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 70 SOUTH AFRICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 71 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 72 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 73 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 74 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 U.A.E. BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 U.A.E. MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 U.A.E. CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 U.A.E. MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 U.A.E. DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 U.A.E. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 81 U.A.E. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 U.A.E. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 83 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 84 U.A.E. METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 85 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 86 U.A.E. INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 87 U.A.E. EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 88 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.A.E. RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 90 U.A.E. TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 91 U.A.E. PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.A.E. ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.A.E. DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 94 U.A.E. ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 97 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 98 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 99 ISRAEL BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 ISRAEL MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 ISRAEL CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 ISRAEL MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 ISRAEL DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 ISRAEL PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 105 ISRAEL PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 ISRAEL PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 107 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 108 ISRAEL METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 109 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 110 ISRAEL INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 111 ISRAEL EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 112 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 113 ISRAEL RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 114 ISRAEL TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 115 ISRAEL PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 116 ISRAEL ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 117 ISRAEL DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 118 ISRAEL ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 119 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 120 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 122 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 EGYPT BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 124 EGYPT MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 125 EGYPT CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 EGYPT MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 EGYPT DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 EGYPT PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 129 EGYPT PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 EGYPT PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 131 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 132 EGYPT METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 133 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 134 EGYPT INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 135 EGYPT EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 136 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 137 EGYPT RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 138 EGYPT TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 139 EGYPT PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 140 EGYPT ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 141 EGYPT DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 142 EGYPT ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 143 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 144 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 145 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 146 REST OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SEGMENTATION
FIGURE 11 INCREASE IN DEMAND FOR PATIENTS SPECIFIC IMPLANTS ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 BONE GRAFT SUBSTITUTE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET IN 2023 & 2030
FIGURE 13 DRIVER, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET
FIGURE 14 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, 2022
FIGURE 15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, 2022
FIGURE 19 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, LIFELINE CURVE
FIGURE 22 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, 2022
FIGURE 23 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, 2022
FIGURE 27 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, 2022
FIGURE 31 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, 2022
FIGURE 35 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 39 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 40 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 41 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SNAPSHOT (2022)
FIGURE 43 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2022)
FIGURE 44 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: TEST TYPE (2023-2030)
FIGURE 47 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
